Hansen Medical Announces First Use of the New Magellan Robotic Microcatheter Driver

November 4, 2015—Hansen Medical, Inc. announced the completion of the first clinical procedure using the company’s Magellan robotic microcatheter driver. The procedure was part of the Embolization Procedures in Peripheral Vasculature clinical study that is being conducted at Hôpital Européen Georges Pompidou in Paris, France. The study’s Principal Investigator, Prof. Marc Sapoval, MD, and Gregory Amouyal, MD, performed the procedure, which was a prostate artery embolization for the treatment of benign prostatic hyperplasia.

In the company’s press release, Prof. Sapoval commented, “We are pleased to complete the world's first clinical procedure using the Magellan microcatheter driver as part of this clinical study. Manual control of microcatheters and microwires can be challenging, particularly in tortuous anatomy. By utilizing the microcatheter driver in conjunction with the Magellan 6-F robotic catheter, we are enhancing the utility of the Magellan robotic system and realizing its potential in a pivotal aspect of embolization procedures.”

According to Hansen Medical, the Magellan robotic microcatheter driver is designed to provide for robotic navigation and control of a wide variety of third-party microcatheters and expands the application of the Magellan robotic system to a greater portion of many endovascular procedures. The Magellan robotic system drives Magellan robotic catheters and guidewires during endovascular procedures. The system is designed to offer procedural predictability, precision, and catheter stability as physicians navigate inside blood vessels and deliver therapy.